Case number 2022-1003
Nektar Therapeutics v. NOF Corporation > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 2, 2022 | 23 | ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [22] filed by Cross-Appellant NOF Corporation. in 22-1003; issuing mandate. Service as of this date by the Clerk of Court. [834223] [22-1003, 22-1004, 22-1008, 22-1060] [JCW] [Entered: 03/02/2022 08:45 AM] (2) |
| Mar 1, 2022 | 22 | MOTION of Cross-Appellant NOF Corporation to voluntarily dismiss appeal pursuant to FRAP 42(b). Service: 03/01/2022 by email. [834201] [22-1003] [Thomas Donovan] [Entered: 03/01/2022 06:15 PM] (3) |
| Feb 15, 2022 | 21 | Docketing Statement for the Intervenor Andrew Hirshfeld. Service: 02/15/2022 by email. [831265] [22-1003] [Sarah Craven] [Entered: 02/15/2022 01:24 PM] (2) |
| Feb 10, 2022 | 20 | **TEXT ONLY** ORDER granting motion to extend time to file brief [19] filed by Cross-Appellant NOF Corporation. The opening brief is due 03/16/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [830323] [JCW] [Entered: 02/10/2022 09:36 AM] (0) |
| Feb 9, 2022 | 19 | MOTION of Cross-Appellant NOF Corporation to extend the time to 03/16/2022 to file brief. Service: 02/09/2022 by email. [830262] [22-1003] [Thomas Donovan] [Entered: 02/09/2022 05:30 PM] (12) |
| Feb 1, 2022 | 18 | ORDER filed. The motion is granted. The PTO is added as an intervenor in the above-captioned appeals. The revised official caption is reflected above. The PTO is directed to file a docketing statement no later than 14 days from the date of filing of this order. NOF Corporation's principal and response brief and the PTO's brief are due no later than 40 days after service of Nektar Therapeutics's principal brief. (see order for details) Service as of this date by the Clerk of Court. [828174] [LMS] [Entered: 02/01/2022 08:38 AM] (2) |
| Jan 14, 2022 | 16 | MOTION of Appellant Nektar Therapeutics to extend the time to 02/23/2022 to file brief. Service: 01/14/2022 by email. [824690] [22-1003] [Kaitlin Farrell] [Entered: 01/14/2022 01:03 PM] (12) |
| Jan 14, 2022 | 17 | **TEXT ONLY** ORDER granting motion to extend time to file brief [16] filed by Appellant Nektar Therapeutics. The opening brief is due 02/23/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [824694] [JCW] [Entered: 01/14/2022 01:15 PM] (0) |
| Jan 11, 2022 | 14 | Notice of Intervention pursuant to the provisions of 35 USC Section 143 from the Director of the United States Patent and Trademark Office. Service: 01/11/2022 by email. [823918] [22-1003] [Sarah Craven] [Entered: 01/11/2022 03:51 PM] (2) |
| Jan 11, 2022 | 15 | Entry of appearance for Sarah E. Craven; Farheena Y. Rasheed; Maureen D. Queler as counsel for Director of the United States Patent and Trademark Office. Service: 01/11/2022 by email. [823921] [22-1003] [Sarah Craven] [Entered: 01/11/2022 03:54 PM] (2) |
| Nov 29, 2021 | 13 | Certified list received. Service: 11/24/2021 by email. Refer to Fed. Cir. R. 31 for calculating brief deadlines from service of the certified list. [814919] [22-1003, 22-1004, 22-1008, 22-1060] [JCW] [Entered: 11/29/2021 09:06 AM] (190) |
| Oct 29, 2021 | 12 | Docketing Statement for the Cross-Appellant NOF Corporation. Service: 10/29/2021 by email. [809250] [22-1003] [Thomas Donovan] [Entered: 10/29/2021 04:49 PM] (2) |
| Oct 20, 2021 | 10 | ORDER consolidating appeals (22-1003, 22-1004, 22-1008, 22-1060). The Certified Lists are due no later than November 24, 2021. Service as of this date by the Clerk of Court. [807070] [22-1003, 22-1060, 22-1004, 22-1008] [JCW] [Entered: 10/20/2021 03:14 PM] (2) |
| Oct 20, 2021 | 11 | Note to File: The following cases are consolidated: 22-1003 Lead with 22-1004, 22-1008 Member Cases, 22-1060 Cross-Appeal. The parties must file all documents in the lead appeal only. [807071] [22-1003, 22-1004, 22-1008, 22-1060] [JCW] [Entered: 10/20/2021 03:17 PM] (0) |
| Oct 19, 2021 | 9 | Docketing Statement for the Appellee NOF Corporation. Service: 10/19/2021 by email. [806844] [22-1003] [Thomas Donovan] [Entered: 10/19/2021 03:21 PM] (2) |
| Oct 15, 2021 | 6 | Certificate of Interest for Appellant Nektar Therapeutics. Service: 10/15/2021 by email. [805898] [22-1003] [Edgar Haug] [Entered: 10/15/2021 10:22 AM] (3) |
| Oct 15, 2021 | 7 | Entry of appearance for Edgar H. Haug; Andrew S. Wasson; Andrew S. Roper; Jonathan A. Herstoff; Kaitlin M. Abrams as counsel for Appellant Nektar Therapeutics. Service: 10/15/2021 by email. [805905] [22-1003] [Edgar Haug] [Entered: 10/15/2021 10:28 AM] (2) |
| Oct 15, 2021 | 8 | Docketing Statement for the Appellant Nektar Therapeutics. Service: 10/15/2021 by email. [805907] [22-1003] [Edgar Haug] [Entered: 10/15/2021 10:30 AM] (2) |
| Oct 8, 2021 | 5 | Certificate of Interest for Appellee NOF Corporation. Service: 10/08/2021 by email. [804572] [22-1003] [Mark Hagedorn] [Entered: 10/08/2021 01:11 PM] (3) |
| Oct 7, 2021 | 4 | Entry of appearance for Thomas Donovan; Mark Hagedorn; Kyle Forgue as counsel for Appellee NOF Corporation. Service: 10/07/2021 by email. [804292] [22-1003] [Mark Hagedorn] [Entered: 10/07/2021 12:32 PM] (2) |
| Oct 5, 2021 | 2 | ORDER consolidating appeals (22-1003, 22-1004, 22-1008). The certified lists are due no later than November 15, 2021. Service as of this date by the Clerk of Court. [803688] [22-1003, 22-1004, 22-1008] [JCW] [Entered: 10/05/2021 01:38 PM] (2) |
| Oct 5, 2021 | 3 | Note to File: The following cases are consolidated: 22-1003 Lead with 22-1004 and 22-1008 Member Cases. The parties must file all documents in the lead appeal only. [803691] [22-1003, 22-1004, 22-1008] [JCW] [Entered: 10/05/2021 01:40 PM] (0) |
| Oct 1, 2021 | 1 | Appeal docketed. Received: 09/30/2021. [803133] Entry of Appearance is due on 10/15/2021. Certificate of Interest is due on 10/15/2021. Docketing Statement is due on 10/15/2021. Certified List is due on 11/10/2021. [JCW] [Entered: 10/01/2021 01:33 PM] (0) |
